CD47 signaling pathways controlling cellular differentiation and responses to stress

Critical Reviews in Biochemistry and Molecular Biology

Volumn 50, Issue 3, 2015, Pages 212-230

  Soto Pantoja, David R ^a   Kaur, Sukhbir ^a   Roberts, David D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Autophagy; hydrogen sulfide; immune regulation; integrin signaling; Myc; nitric oxide; radioresistance; stem cells

Indexed keywords

CALCIUM; CD47 ANTIGEN; CYCLIC NUCLEOTIDE; FAS ANTIGEN; HYDROGEN SULFIDE; INTEGRIN; MEMBRANE RECEPTOR; MYC PROTEIN; NITRIC OXIDE; PROTEIN; SIGNAL REGULATORY PROTEIN ALPHA; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CD47 PROTEIN, HUMAN;

AUTOPHAGY; BINDING AFFINITY; BIOGENESIS; BIOSYNTHESIS; CALCIUM HOMEOSTASIS; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL DEATH; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CELL MOTILITY; CELL STRESS; CELL SURVIVAL; CHRONIC DISEASE; CYTOPLASM; CYTOSKELETON; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; ERYTHROCYTE; EUKARYOTIC CELL; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOREGULATION; INFLAMMATION; IONIZING RADIATION; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REDOX STRESS; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STRUCTURE ANALYSIS; T LYMPHOCYTE ACTIVATION; ANIMAL; CHEMISTRY; CYTOLOGY; GENE REGULATORY NETWORK; IMMUNOLOGY; MACROPHAGE; METABOLISM; PATHOLOGY;

ANIMALS; ANTIGENS, CD47; CELL DIFFERENTIATION; CELL SURVIVAL; GENE REGULATORY NETWORKS; HUMANS; INFLAMMATION; MACROPHAGES; SIGNAL TRANSDUCTION;

EID: 84937717236     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.3109/10409238.2015.1014024     Document Type: Review

References (163)

1. Adams JC, Bentley AA, Kvansakul M, et al. (2008). Extracellular matrix retention of thrombospondin 1 is controlled by its conserved C-terminal region. J Cell Sci 121:784-95.
2. Avent ND, Madgett TE, Lee ZE, et al. (2006). Molecular biology of Rh proteins and relevance to molecular medicine. Expert Rev Mol Med 8: 1-20.
3. Azcutia V, Routledge M, Williams MR, et al. (2013). CD47 plays a critical role in T-cell recruitment by regulation of LFA-1 and VLA-4 integrin adhesive functions. Mol Biol Cell 24:3358-68.
4. Bamberger ME, Harris ME, Mcdonald DR, et al. (2003). A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J Neurosci 23:2665-74.
5. Barazi HO, Li Z, Cashel JA, et al. (2002). Regulation of integrin function by CD47 ligands. Differential effects on avb3 and a4b1 integrin-mediated adhesion. J Biol Chem 277:42859-66.
6. Barclay AN, Van Den Berg TK. (2014). The interaction between signal regulatory protein alpha (SIRPalpha) and CD47: structure, function, and therapeutic target. Annu Rev Immunol 32:25-50.
7. Bauer EM, Qin Y, Miller TW, et al. (2010). Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc Res 88:471-81.
8. Bernardi B, Guidetti GF, Campus F, et al. (2006). The small GTPase Rap1b regulates the cross talk between platelet integrin alpha2beta1 and integrin alphaIIbbeta3. Blood 107:2728-35.
9. Bjorkoy G, Lamark T, Pankiv S, et al. (2009). Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol 452:181-97.
10. Bras M, Yuste VJ, Roue G, et al. (2007). Drp1 mediates caspaseindependent type III cell death in normal and leukemic cells. Mol Cell Biol 27:7073-88.
11. Brittain JE, Han J, Ataga KI, et al. (2004). Mechanism of CD47-induced alpha4beta1 integrin activation and adhesion in sickle reticulocytes. J Biol Chem 279:42393-402.
12. Brooke G, Holbrook JD, Brown MH, Barclay AN. (2004). Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family. J Immunol 173:2562-70.
13. Burger P, De Korte D, Van Den Berg TK, Van Bruggen R. (2012). CD47 in erythrocyte ageing and clearance-the Dutch point of view. Transfus Med Hemother 39:348-52.
14. Cambot M, Mazurier C, Canoui-Poitrine F, et al. (2013). In vitro generated Rh(null) red cells recapitulate the in vivo deficiency: a model for rare blood group phenotypes and erythroid membrane disorders. Am J Hematol 88:343-9.
15. Campbell IG, Freemont PS, Foulkes W, Trowsdale J. (1992). An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains. Cancer Res 52:5416-20.
16. Cant CA, Ullrich A. (2001). Signal regulation by family conspiracy. Cell Mol Life Sci 58:117-24.
17. Chandrasekaran S, Guo N, Rodrigues RG, et al. (1999). Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cella are mediated by a3b1 integrin and regulated by insulin-like growth factor-1 and CD98. J Biol Chem 274:11408-16.
18. Chang CR, Blackstone C. (2007). Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. J Biol Chem 282:21583-7.
19. Chao MP, Alizadeh AA, Tang C, et al. (2011). Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia. Cancer Res 71:1374-84.
20. Chao MP, Weissman IL, Majeti R. (2012). The CD47-SIRPalpha pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol 24:225-32.
21. Chu LY, Ramakrishnan DP, Silverstein RL. (2013). Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells. Blood 122:1822-32.
22. Chung J, Gao AG, Frazier WA. (1997). Thrombspondin acts via integrinassociated protein to activate the platelet integrin aIIbb3. J Biol Chem 272:14740-6.
23. Chung J, Wang XQ, Lindberg FP, Frazier WA. (1999). Thrombospondin-1 acts via IAP/CD47 to synergize with collagen in alpha2beta1-mediated platelet activation. Blood 94:642-8.
24. Csanyi G, Yao M, Rodriguez AI, et al. (2012). Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1. Arterioscler Thromb Vasc Biol 32:2966-73.
25. Dahl KN, Westhoff CM, Discher DE. (2003). Fractional attachment of CD47 (IAP) to the erythrocyte cytoskeleton and visual colocalization with Rh protein complexes. Blood 101:1194-9.
26. Dang CV. (2013). MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb Perspect Med 3. doi: 10.1101/cshperspect.a014217.
27. Dong X, Mi LZ, Zhu J, et al. (2012). alpha(V)beta(3) integrin crystal structures and their functional implications. Biochemistry 51: 8814-28.
28. Dorahy DJ, Thorne RF, Fecondo JV, Burns GF. (1997). Stimulation of platelet activation and aggregation by a carboxyl-terminal peptide from thrombospondin binding to the integrin-associated protein receptor. J Biol Chem 272:1323-30.
29. Drbal K, Cerny J, Angelisova P, et al. (2000). CDw149 antibodies recognize a clustered subset of CD47 molecules associated with cytoplasmic signaling molecules. Tissue Antigens 56:258-67.
30. Edris B, Weiskopf K, Volkmer AK, et al. (2012). Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma. Proc Natl Acad Sci USA 109:6656-61.
31. Flatt JF, Musa RH, Ayob Y, et al. (2012). Study of the D-phenotype reveals erythrocyte membrane alterations in the absence of RHCE. Br J Haematol 158:262-73.
32. Floquet N, Dedieu S, Martiny L, et al. (2008). Human thrombospondin's (TSP-1) C-terminal domain opens to interact with the CD-47 receptor: a molecular modeling study. Arch Biochem Biophys 478:103-9.
33. Frazier EP, Isenberg JS, Shiva S, et al. (2011). Age-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47. Matrix Biol 30:154-61.
34. Frazier WA, Gao A-G, Dimitry J, et al. (1999). The thrombospondin receptor integrin-associated protein (CD47) functionally couples to heterotrimeric Gi. J Biol Chem 274:8554-60.
35. Fujimoto TT, Katsutani S, Shimomura T, Fujimura K. (2003). Thrombospondin-bound integrin-associated protein (CD47) physically and functionally modifies integrin alphaIIbbeta3 by its extracellular domain. J Biol Chem 278:26655-65.
36. Gao A-G, Lindberg FP, Finn MB, et al. (1996). Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 271:21-4.
37. Grimbert P, Bouguermouh S, Baba N, et al. (2006). Thrombospondin/CD47 interaction: a pathway to generate regulatory T cells from human CD4+CD25-T cells in response to inflammation. J Immunol 177:3534-41.
38. Grunewald FS, Prota AE, Giese A, Ballmer-Hofer K. (2010). Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling. Biochim Biophys Acta 1804:567-80.
39. Guo N, Zabrenetzky VS, Chandrasekaran L, et al. (1998). Differential Roles of protein kinase C and pertussis toxin-sensitive G-binding proteins in modulation of melanoma cell proliferation and motility by thrombospondin-1. Cancer Res 58:3154-62.
40. Gupta K, Gupta P, Wild R, et al. (1999). Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis. Angiogenesis 3:147-58.
41. Hanna RA, Quinsay MN, Orogo AM, et al. (2012). Microtubuleassociated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J Biol Chem 287:19094-104.
42. Hatherley D, Graham SC, Turner J, et al. (2008). Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47. Mol Cell 31:266-77.
43. Isenberg JS, Annis DS, Pendrak ML, et al. (2009a). Differential interactions of thrombospondin-1,-2, and-4 with CD47 and effects on cGMP signaling and ischemic injury responses. J Biol Chem 284: 1116-25.
44. Isenberg JS, Hyodo F, Pappan LK, et al. (2007a). Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia. Arterioscler Thromb Vasc Biol 27: 2582-8.
45. Isenberg JS, Jia Y, Fukuyama J, et al. (2007b). Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake. J Biol Chem 282:15404-15.
46. Isenberg JS, Martin-Manso G, Maxhimer JB, Roberts DD. (2009b). Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nat Rev Cancer 9:182-94.
47. Isenberg JS, Maxhimer JB, Hyodo F, et al. (2008a). Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury. Am J Pathol 173:1100-12.
48. Isenberg JS, Maxhimer JB, Powers P, et al. (2008b). Treatment of ischemia/reperfusion injury by limiting thrombospondin-1/CD47 signaling. Surgery 144:752-61.
49. Isenberg JS, Pappan LK, Romeo MJ, et al. (2008c). Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts. Ann Surg 247:180-90.
50. Isenberg JS, Qin Y, Maxhimer JB, et al. (2009c). Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress. Matrix Biol 28:110-19.
51. Isenberg JS, Ridnour LA, Dimitry J, et al. (2006). CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 281:26069-80.
52. Isenberg JS, Romeo MJ, Abu-Asab M, et al. (2007c). Increasing survival of ischemic tissue by targeting CD47. Circ Res 100:712-20.
53. Isenberg JS, Romeo MJ, Yu C, et al. (2008d). Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling. Blood 111:613-23.
54. Ishihara M, Urushido M, Hamada K, et al. (2013). Sestrin-2 and BNIP3 regulate autophagy and mitophagy in renal tubular cells in acute kidney injury. Am J Physiol Renal Physiol 305:F495-509.
55. Jin G, Tsuji K, Xing C, et al. (2009). CD47 gene knockout protects against transient focal cerebral ischemia in mice. Exp Neurol 217: 165-70.
56. Kalas W, Swiderek E, Rapak A, et al. (2011). H-ras up-regulates expression of BNIP3. Anticancer Res 31:2869-75.
57. Kalas W, Swiderek E, Switalska M, et al. (2013). Thrombospondin-1 receptor mediates autophagy of RAS-expressing cancer cells and triggers tumour growth inhibition. Anticancer Res 33:1429-38.
58. Kaur S, Chang T, Singh SP, et al. (2014a). CD47 signaling regulates the immunosuppressive activity of VEGF in T cells. J Immunol 193: 3914-24.
59. Kaur S, Kuznetsova SA, Pendrak ML, et al. (2011). Heparan sulfate modification of the transmembrane receptor CD47 is necessary for inhibition of T cell receptor signaling by thrombospondin-1. J Biol Chem 286:14991-5002.
60. Kaur S, Martin-Manso G, Pendrak ML, et al. (2010). Thrombospondin-1 inhibits vascular endothelial growth factor receptor-2 signaling by disrupting its association with CD47. J Biol Chem 285: 38923-32.
61. Kaur S, Singh SP, Elkahloun AG, et al. (2014b). CD47-dependent immunomodulatory and angiogenic activities of extracellular vesicles produced by T cells. Matrix Biol 37:49-59.
62. Kaur S, Soto-Pantoja DR, Stein EV, et al. (2013). Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors. Sci Rep 3:1673. doi: 10.1038/srep01673.
63. Kershaw MH, Smyth MJ. (2013). Immunology. Making macrophages eat cancer. Science 341:41-2.
64. Kim HS, Choi DY, Yun SJ, et al. (2012). Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res 11:839-49.
65. Kim MJ, Lee JC, Lee JJ, et al. (2008). Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines. Tumour Biol 29:28-34.
66. Kolluru GK, Shen X, Bir SC, Kevil CG. (2013). Hydrogen sulfide chemical biology: pathophysiological roles and detection. Nitric Oxide 35:5-20.
67. Kosfeld MD, Frazier WA. (1993). Identification of a new cell adhesion motif in two homologous peptides from the COOH-terminal cell binding domain of human thrombospondin. J Biol Chem 268: 8808-14.
68. Kvansakul M, Adams JC, Hohenester E. (2004). Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats. EMBO J 23:1223-33.
69. Lamy L, Foussat A, Brown EJ, et al. (2007). Interactions between CD47 and thrombospondin reduce inflammation. J Immunol 178:5930-9.
70. Lamy L, Ticchioni M, Rouquette-Jazdanian AK, et al. (2003). CD47 and the 19 kDa interacting protein-3 (BNIP3) in T cell apoptosis. J Biol Chem 278:23915-21.
71. Latour S, Tanaka H, Demeure C, et al. (2001). Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. J Immunol 167:2547-54.
72. Leclair P, Lim CJ. (2014). CD47-independent effects mediated by the TSP-derived 4N1K peptide. PLoS One 9:e98358.
73. Lee DY, Arnott D, Brown EJ. (2013a). Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the autophagy machinery. EMBO Rep 14: 373-81.
74. Lee JE, Jeon IS, Han NE, et al. (2013b). Ubiquilin 1 interacts with Orai1 to regulate calcium mobilization. Mol Cells 35:41-6.
75. Li SS, Liu Z, Uzunel M, Sundqvist KG. (2006). Endogenous thrombospondin-1 is a cell surface ligand for regulation of integrin dependent T lymphocyte adhesion. Blood 108:3112-20.
76. Li Z, Calzada MJ, Sipes JM, et al. (2002). Interactions of thrombospondins with a4b1 integrin and CD47 differentially modulate T cell behavior. J Cell Biol 157:509-19.
77. Li Z, He L, Wilson KE, Roberts DD. (2001). Thrombospondin-1 inhibits TCR-mediated T lymphocyte early activation. J Immunol 166: 2427-36.
78. Lin Y, Manning PT, Jia J, et al. (2014). CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model. Transplantation 98:394-401.
79. Lindberg FP, Bullard DC, Caver TE, et al. (1996a). Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 274:795-8.
80. Lindberg FP, Gresham HD, Reinhold MI, Brown EJ. (1996b). Integrinassociated protein immunoglobulin domain is necessary for efficient vitronectin bead binding. J Cell Biol 134:1313-22.
81. Lindberg FP, Gresham HD, Schwarz E, Brown EJ. (1993). Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane-spanning domains implicated in alpha v beta 3-dependent ligand binding. J Cell Biol 123:485-96.
82. Liu Y, Lu L, Hettinger CL, et al. (2014). Ubiquilin-1 protects cells from oxidative stress and ischemic stroke caused tissue injury in mice. J Neurosci 34:2813-21.
83. Maile LA, Allen LB, Hanzaker CF, et al. (2010). Glucose regulation of thrombospondin and its role in the modulation of smooth muscle cell proliferation. Exp Diabetes Res 2010: 617052.
84. Maile LA, Capps BE, Miller EC, et al. (2008a). Integrin-associated protein association with SRC homology 2 domain containing tyrosine phosphatase substrate 1 regulates igf-I signaling in vivo. Diabetes 57: 2637-43.
85. Maile LA, Capps BE, Miller EC, et al. (2008b). Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I. Mol Endocrinol 22:1226-37.
86. Maile LA, Clemmons DR. (2003). Integrin-associated protein binding domain of thrombospondin-1 enhances insulin-like growth factor-I receptor signaling in vascular smooth muscle cells. Circ Res 93: 925-31.
87. Majeti R, Chao MP, Alizadeh AA, et al. (2009). CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 138:286-99.
88. Manna PP, Dimitry J, Oldenborg PA, Frazier WA. (2005). CD47 augments Fas/CD95-mediated apoptosis. J Biol Chem 280:29637-44.
89. Manna PP, Frazier WA. (2003). The mechanism of CD47-dependent killing of T cells: heterotrimeric Gi-dependent inhibition of protein kinase A. J Immunol 170:3544-53.
90. Martin-Manso G, Galli S, Ridnour LA, et al. (2008). Thrombospondin-1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity by differentiated U937 cells. Cancer Res 68:7090-9.
91. Martinelli R, Newton G, Carman CV, et al. (2013). Novel role of CD47 in rat microvascular endothelium: signaling and regulation of T-cell transendothelial migration. Arterioscler Thromb Vasc Biol 33: 2566-76.
92. Mateo V, Brown EJ, Biron G, et al. (2002). Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization. Blood 100:2882-90.
93. Matozaki T, Murata Y, Okazawa H, Ohnishi H. (2009). Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway. Trends Cell Biol 19:72-80.
94. Mawby WJ, Holmes CH, Anstee DJ, et al. (1994). Isolation and characterization of CD47 glycoprotein: a multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3. Biochem J 304:525-30.
95. Maxhimer JB, Shih HB, Isenberg JS, et al. (2009a). Thrombospondin-1-CD47 blockade following ischemia reperfusion injury is tissue protective. Plast Reconstr Surg 124:1880-9.
96. Maxhimer JB, Soto-Pantoja DR, Ridnour LA, et al. (2009b). Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling. Sci Transl Med 1:3ra7.
97. Mcdonald JF, Dimitry JM, Frazier WA. (2003). An amyloid-like C-terminal domain of thrombospondin-1 displays CD47 agonist activity requiring both VVM motifs. Biochemistry 42:10001-11.
98. Mcdonald JF, Zheleznyak A, Frazier WA. (2004). Cholesterolindependent interactions with CD47 enhance alphavbeta3 avidity. J Biol Chem 279:17301-11.
99. Miller TW, Isenberg JS, Roberts DD. (2010a). Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase. Br J Pharmacol 159:1542-7.
100. Miller TW, Isenberg JS, Shih HB, et al. (2010b). Amyloid-beta inhibits No-cGMP signaling in a CD36-and CD47-dependent manner. PLoS One 5:e15686.
101. Miller TW, Kaur S, Ivins-O'keefe K, Roberts DD. (2013). Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation. Matrix Biol 32: 316-24.
102. Miller TW, Wang EA, Gould S, et al. (2012). Hydrogen sulfide is an endogenous potentiator of T cell activation. J Biol Chem 287: 4211-21.
103. Mittal R, Gonzalez-Gomez I, Prasadarao NV. (2010). Escherichia coli K1 promotes the ligation of CD47 with thrombospondin-1 to prevent the maturation of dendritic cells in the pathogenesis of neonatal meningitis. J Immunol 185:2998-3006.
104. Miyashita M, Ohnishi H, Okazawa H, et al. (2004). Promotion of neurite and filopodium formation by CD47: roles of integrins, Rac, and Cdc42. Mol Biol Cell 15:3950-63.
105. Mouro-Chanteloup I, Delaunay J, Gane P, et al. (2003). Evidence that the red cell skeleton protein 4.2 interacts with the Rh membrane complex member CD47. Blood 101:338-44.
106. Mushegian A. (2002). Refining structural and functional predictions for secretasome components by comparative sequence analysis. Proteins 47:69-74.
107. N'diaye EN, Brown EJ. (2003). The ubiquitin-related protein PLIC-1 regulates heterotrimeric G protein function through association with Gbetagamma. J Cell Biol 163: 1157-65.
108. Nishiyama Y, Tanaka T, Naitoh H, et al. (1997). Overexpression of integrin-associated protein (CD47) in rat kidney treated with a renal carcinogen, ferric nitrilotriacetate. Jpn J Cancer Res 88:120-8.
109. Nisoli E, Carruba MO. (2006). Nitric oxide and mitochondrial biogenesis. J Cell Sci 119:2855-62.
110. Oldenborg PA, Gresham HD, Lindberg FP. (2001). CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis. J Exp Med 193:855-62.
111. Oldenborg PA, Zheleznyak A, Fang YF, et al. (2000). Role of CD47 as a marker of self on red blood cells. Science 288:2051-4.
112. Per-Arne O. (2012). Role of CD47 and signal regulatory protein alpha (SIRPalpha) in regulating the clearance of viable or aged blood cells. Transfus Med Hemother 39:315-20.
113. Pettersen RD, Hestdal K, Olafsen MK, et al. (1999). CD47 signals T cell death. J Immunol 162:7031-40.
114. Pfeiffer A, Bottcher A, Orso E, et al. (2001). Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur J Immunol 31:3153-64.
115. Qin Q, Qian J, Ge L, et al. (2014). Effect and mechanism of thrombospondin-1 on the angiogenesis potential in human endothelial progenitor cells: an in vitro study. PLoS One 9:e88213.
116. Ramanathan S, Mazzalupo S, Boitano S, Montfort WR. (2011). Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration. Biochemistry 50:7787-99.
117. Rebres RA, Green JM, Reinhold MI, et al. (2001a). Membrane raft association of CD47 is necessary for actin polymerization and protein kinase C theta translocation in its synergistic activation of T cells. J Biol Chem 276:7672-80.
118. Rebres RA, Kajihara K, Brown EJ. (2005). Novel CD47-dependent intercellular adhesion modulates cell migration. J Cell Physiol 205: 182-93.
119. Rebres RA, Vaz LE, Green JM, Brown EJ. (2001b). Normal ligand binding and signaling by CD47 (integrin-associated protein) requires a long range disulfide bond between the extracellular and membrane spanning domains. J Biol Chem 276:34607-16.
120. Rho J, Chung J, Im H, et al. (2013). Magnetic nanosensor for detection and profiling of erythrocyte-derived microvesicles. ACS Nano 7: 11227-33.
121. Rogers NM, Thomson AW, Isenberg JS. (2012). Activation of parenchymal CD47 promotes renal ischemia-reperfusion injury. J Am Soc Nephrol 23:1538-50.
122. Rothenberg C, Srinivasan D, Mah L, et al. (2010). Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. Hum Mol Genet 19:3219-32.
123. Sadallah S, Eken C, Martin PJ, Schifferli JA. (2011). Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. J Immunol 186: 6543-52.
124. Sarfati M, Fortin G, Raymond M, Susin S. (2008). CD47 in the immune response: role of thrombospondin and SIRP-alpha reverse signaling. Curr Drug Targets 9:842-50.
125. Schon P, Vischer P, Volker W, et al. (1992). Cell-associated proteoheparan sulfate mediates binding and uptake of thrombospondin in cultured porcine vascular endothelial cells. Eur J Cell Biol 59: 329-39.
126. Schwartz MA, Brown EJ, Fazeli B. (1993). A 50-kDa integrin-associated protein is required for integrin-regulated calcium entry in endothelial cells. J Biol Chem 268:19931-4.
127. Shaked Y, Bertolini F, Man S, et al. (2005). Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell 7:101-11.
128. Sharifi-Sanjani M, Shoushtari AH, Quiroz M, et al. (2014). Cardiac CD47 drives left ventricular heart failure through Ca2+-CaMKIIregulated induction of HDAC3. J Am Heart Assoc 3:e000670.
129. Shibuya M. (2006). Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 39:469-78.
130. Shinohara M, Ohyama N, Murata Y, et al. (2006). CD47 regulation of epithelial cell spreading and migration, and its signal transduction. Cancer Sci 97:889-95.
131. Sick E, Boukhari A, Deramaudt T, et al. (2011). Activation of CD47 receptors causes proliferation of human astrocytoma but not normal astrocytes via an Akt-dependent pathway. Glia 59:308-19.
132. Sick E, Jeanne A, Schneider C, et al. (2012). CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest. Br J Pharmacol 167:1415-30.
133. Sipes JM, Krutzsch HC, Lawler J, Roberts DD. (1999). Cooperation between thrombospondin-1 type 1 repeat peptides and integrin avb3 ligands to promote melanoma cell spreading and focal adhesion formation. J Biol Chem 274:22755-62.
134. Smadja DM, D'audigier C, Bieche I, et al. (2011). Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties. Arterioscler Thromb Vasc Biol 31:551-9.
135. Soto-Pantoja DR, Kaur S, Miller TW, et al. (2013a). Leukocyte surface antigen CD47. UCSD Molecule Pages 2:19-36.
136. Soto-Pantoja DR, Miller TW, Pendrak ML, et al. (2012). CD47 deficiency confers cell and tissue radioprotection by activation of autophagy. Autophagy 8:1628-42.
137. Soto-Pantoja DR, Ridnour LA, Wink DA, Roberts DD. (2013b). Blockade of CD47 increases survival of mice exposed to lethal total body irradiation. Sci Rep 3:1038. doi: 10.1038/srep01038.
138. Soto-Pantoja DR, Shih HB, Maxhimer JB, et al. (2014a). Thrombospondin-1 and CD47 signaling regulate healing of thermal injury in mice. Matrix Biol 37:25-34.
139. Soto-Pantoja DR, Terabe M, Ghosh A, et al. (2014b). CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy. Cancer Res 74:6771-83.
140. Su X, Johansen M, Looney MR, et al. (2008). CD47 deficiency protects mice from lipopolysaccharide-induced acute lung injury and Escherichia coli pneumonia. J Immunol 180:6947-53.
141. Subramanian S, Boder ET, Discher DE. (2007). Phylogenetic divergence of CD47 interactions with human signal regulatory protein alpha reveals locus of species specificity. Implications for the binding site. J Biol Chem 282:1805-18.
142. Subramanian S, Parthasarathy R, Sen S, et al. (2006a). Species-and cell type-specific interactions between CD47 and human SIRPalpha. Blood 107:2548-56.
143. Subramanian S, Tsai R, Sen S, et al. (2006b). Membrane mobility and clustering of Integrin Associated Protein (IAP, CD47)-major differences between mouse and man and implications for signaling. Blood Cells Mol Dis 36:364-72.
144. Swendeman S, Mendelson K, Weskamp G, et al. (2008). VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling. Circ Res 103:916-18.
145. Takahashi K, Yamanaka S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-76.
146. Tibben JG, Massuger LF, Claessens RA, et al. (1992). Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer. Nucl Med Commun 13:885-93.
147. Tsai RK, Discher DE. (2008). Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J Cell Biol 180:989-1003.
148. Tulasne D, Judd BA, Johansen M, et al. (2001). C-terminal peptide of thrombospondin-1 induces platelet aggregation through the Fc receptor gamma-chain-associated signaling pathway and by agglutination. Blood 98:3346-52.
149. Umemori H, Sanes JR. (2008). Signal regulatory proteins (SIRPS) are secreted presynaptic organizing molecules. J Biol Chem 283: 34053-61.
150. Unanue ER. (2013). Perspectives on anti-CD47 antibody treatment for experimental cancer. Proc Natl Acad Sci USA 110:10886-7.
151. Van Kim CL, Colin Y, Cartron JP. (2006). Rh proteins: key structural and functional components of the red cell membrane. Blood Rev 20: 93-110.
152. Van Ravenswaay Claasen HH, Eggermont AM, Nooyen YA, et al. (1994). Immunotherapy in a human ovarian cancer xenograft model with two bispecific monoclonal antibodies: OV-TL 3/CD3 and OC/TR. Gynecol Oncol 52:199-206.
153. Vasagiri N, Kutala VK. (2014). Structure, function, and epigenetic regulation of BNIP3: a pathophysiological relevance. Mol Biol Rep 41:7705-14.
154. Verdrengh M, Lindberg FP, Ryden C, Tarkowski A. (1999). Integrinassociated protein (IAP)-deficient mice are less susceptible to developing Staphylococcus aureus-induced arthritis. Microbes Infect 1:745-51.
155. Wang XQ, Lindberg FP, Frazier WA. (1999). Integrin-associated protein stimulates alpha2beta1-dependent chemotaxis via Gi-mediated inhibition of adenylate cyclase and extracellular-regulated kinases. J Cell Biol 147:389-400.
156. Willingham SB, Volkmer JP, Gentles AJ, et al. (2012). The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci USA 109: 6662-7.
157. Wu AL, Wang J, Zheleznyak A, Brown EJ. (1999). Ubiquitin-related proteins regulate interaction of vimentin intermediate filaments with the plasma membrane. Mol Cell 4:619-25.
158. Xing C, Lee S, Kim WJ, et al. (2009). Role of oxidative stress and caspase 3 in CD47-mediated neuronal cell death. J Neurochem 108: 430-6.
159. Xu D, Fuster MM, Lawrence R, Esko JD. (2011). Heparan sulfate regulates VEGF165-and VEGF121-mediated vascular hyperpermeability. J Biol Chem 286:737-45.
160. Yamauchi Y, Kuroki M, Imakiire T, et al. (2002). Opposite effects of thrombospondin-1 via CD36 and CD47 on homotypic aggregation of monocytic cells. Matrix Biol 21:441-8.
161. Yao M, Roberts DD, Isenberg JS. (2011). Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP. Pharmacol Res 63:13-22.
162. Zhang X, Kazerounian S, Duquette M, et al. (2009). Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level. FASEB J 23:3368-76.
163. Zhang X, Lanahan AA, Simons M. (2013). VEGFR2 trafficking: speed doesn't kill. Cell Cycle 12:2163-4.